"The lack of side effects with NTI164 and the significant clinical improvements we've observed in these patients necessitates a long term treatment plan."
Funds from the sale will be used to provide additional working capital for the Ecofibre group as it continues to refine its focus on core businesses and reduce debt.
So anyway, it is always pain trying to find/remember all of them, so I've made a listicle to make it easy for everyone. Here's your current list of Australian listed potstocks.
The poll result for the question framed around support for the legal use of Marijuana is now sitting at 70%. This represents a massive shift in the past six decades from 12% to 70%.
NTI164 is a proprietary drug formulation derived from a unique cannabis strain with low THC (M<0.3%) and a novel combination of cannabinoids including CBDA, CBC, CBDP, CBDB and CBN.
Incannex Healthcare Inc. (NASDAQ: IXHL) has redomiciled Incannex Healthcare from Australia to the United States, November 28, 2023 New York time (November 29, 2023 Melbourne time).